Evaluation of the Immunogenicity of Meningococcal B (4CMenB) and Meningococcal ACWY (MenACWY Conjugate) Vaccination in a Population With HIV at 12 and 24 Months After Two Doses of Vaccine
Latest Information Update: 05 Jul 2023
At a glance
- Drugs Meningococcal vaccine group B OMV Novartis (Primary) ; Meningococcal vaccine groups A B C Y W-135 conjugate (Primary)
- Indications Meningococcal group B infections
- Focus Pharmacodynamics
Most Recent Events
- 27 Jan 2022 Status changed from not yet recruiting to recruiting.
- 04 Feb 2020 New trial record